Their ovarian cancer diagnostic looks good. I think the problem is that they will need money to develop it and they have little at the moment. I have been following the stock for a while but at the moment am waiting. I have seen too many great ideas fail because companies have been unable to secure funding.
For all holders, I certainly hope this isn't one of the companies that fail.
--
My advice is free and worth every cent
